Needelman Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,215
Closed -$1.48M 11
2018
Q2
$1.48M Hold
6,215
3.22% 11
2018
Q1
$1.36M Sell
6,215
-30
-0.5% -$7.05K 2.94% 14
2017
Q4
$1.41M Sell
6,245
-1,895
-23% -$404K 3.51% 8
2017
Q3
$1.55M Sell
8,140
-730
-8% -$139K 3.8% 3
2017
Q2
$1.67M Sell
8,870
-375
-4% -$67.4K 4.3% 3
2017
Q1
$1.53M Sell
9,245
-30
-0.3% -$4.77K 4.09% 3
2016
Q4
$1.33M Sell
9,275
-95
-1% -$12.7K 3.69% 5
2016
Q3
$1.17M Sell
9,370
-10
-0.1% -$1.29K 3.53% 7
2016
Q2
$1.23M Hold
9,380
3.52% 6
2016
Q1
$1.3M Buy
9,380
+155
+2% +$20.7K 3.82% 5
2015
Q4
$1.29M Sell
9,225
-30
-0.3% -$4.13K 3.9% 3
2015
Q3
$1.3M Hold
9,255
4.26% 3
2015
Q2
$1.52M Sell
9,255
-285
-3% -$45.5K 4.81% 2
2015
Q1
$1.47M Sell
9,540
-75
-0.8% -$10.7K 4.47% 3
2014
Q4
$1.21M Hold
9,615
3.7% 7
2014
Q3
$1.15M Sell
9,615
-190
-2% -$21.8K 3.69% 7
2014
Q2
$1.05M Hold
9,805
3.33% 8
2014
Q1
$976K Sell
9,805
-320
-3% -$28.9K 3.17% 11
2013
Q4
$935K Buy
10,125
+1,475
+17% +$131K 3.09% 17
2013
Q3
$723K Sell
8,650
-20
-0.2% -$1.71K 2.59% 23
2013
Q2
$710K Buy
+8,670
New +$649K 2.59% 21

Other funds holding ELV

Needelman Asset Management's ELV Position: Q3 2018 in Review

Needelman Asset Management sold out of Elevance Health (ELV) in Q3 2018, closing a stake of 6,215 shares — an estimated $1.48M sold.

Needelman Asset Management first reported a position in ELV in Q2 2013 and held it in 21 quarters. The position peaked at $1.67M in Q2 2017. 945 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

  • Needelman Asset Management reported no remaining Elevance Health position as of Q3 2018 after selling out during the quarter.
  • Needelman Asset Management sold 6,215 Elevance Health shares in Q3 2018, an estimated $1.48M.
  • Needelman Asset Management first reported a position in Elevance Health in Q2 2013 and held it in 21 quarters.
  • Needelman Asset Management's Elevance Health position peaked at $1.67M in Q2 2017.
  • 945 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on Needelman Asset Management's 13F filing for Q3 2018.